米国市場銘柄情報

LFST ライフスタンス・ヘルス・グループ

銘柄追加

6.530
+0.080+1.24%

終値 05/02 16:00 ET

6.530
0.0000.00%

市場後 16:02 ET

24.96億時価総額-12803直近PER

ライフスタンス・ヘルス・グループに関するコメント

ログインコメントを投稿

Moomoo AI

03/21 21:53

LifeStance Health Group's positive outlook appears to be priced in, but its high growth potential at a fair price makes it an attractive investment. Higher cash flow is expected, potentially leading to a higher share valuation.

Is LifeStance Health Group, Inc. (NASDAQ:LFST) Potentially Undervalued?

Moomoo AI

03/12 21:11

LifeStance's CEO, Ken Burdick, is confident that Dr. DeLuca's skills will complement the board as they expand mental healthcare access. Dr. DeLuca is excited to join and help more patients receive personalized care.

Press Release: LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

Moomoo AI

02/29 18:30

LifeStance Health Group's high P/S ratio reflects market expectations of continued strong revenue growth. Investors may overpay if these expectations aren't met, but strong future revenue forecasts suggest a decrease in revenues is unlikely.

Why Investors Shouldn't Be Surprised By LifeStance Health Group, Inc.'s (NASDAQ:LFST) 32% Share Price Surge

Moomoo AI

02/14 22:16

Despite top line growth, LifeStance Health Group is incurring a loss of US$145m on the EBIT line. The company's balance sheet, burdened with liabilities against cash, is deemed unfit and risky.

Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt

Moomoo AI

01/19 22:10

CEO Ken Burdick is confident in Dr. Ramtekkar's ability to drive exceptional patient and clinical outcomes, citing his commitment to clinical excellence. Dr. Ramtekkar is excited to join LifeStance and continue setting the bar for clinical excellence in mental health.

Press Release: LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer

Moomoo AI

01/10 21:57

Multiple insiders selling shares could be a red flag. However, the President & COO's large sale was at a high price. High insider ownership suggests management's interest in shareholders, but lack of insider purchases doesn't instill confidence.

Insiders At LifeStance Health Group Sold US$3.8m In Stock, Alluding To Potential Weakness

Moomoo AI

2023/12/07 11:36

LifeStance Health Group's higher P/S ratio is likely due to anticipation of continued robust revenue performance. Shareholders seem at ease with this P/S, confident in the company's future revenue prospects and expecting it to outperform its industry.